Can a Daily Multivitamin Slow Your Biological Aging? What the COSMOS Trial Found
Most people take a daily multivitamin to fill nutritional gaps, insure against an imperfect diet, or simply as a long-standing habit. A landmark study published in Nature Medicine in March 2026 suggests that a daily multivitamin may be doing something more: measurably slowing the biological clock itself. The COSMOS trial — one of the largest and most rigorous randomized controlled trials on supplements ever conducted — found that participants who took a multivitamin for two years experienced approximately four months less biological aging compared to those who took a placebo. That finding is more interesting, and more nuanced, than most of the headlines that covered it.
What the COSMOS Trial Found
The COcoa Supplement and Multivitamin Outcomes Study (COSMOS) was a large, multi-year clinical trial that examined the effects of two interventions — a daily multivitamin-multimineral supplement and cocoa extract — on a range of health outcomes in older adults. The ancillary study focused specifically on biological aging, measured through epigenetic clocks.
Study Design
The ancillary study enrolled 958 participants from the main COSMOS cohort. Participants were randomly assigned to receive either a daily multivitamin-multimineral supplement (Centrum Silver), a cocoa extract supplement, both, or a placebo, and were followed for two years. Biological aging was measured using five established DNA methylation-based epigenetic clocks: PCHannum, PCHorvath, PCPhenoAge, PCGrimAge, and DunedinPACE. Blood samples were collected at baseline and at the two-year follow-up to assess changes in these clocks.
Key Results
Compared to placebo, daily multivitamin supplementation modestly but significantly slowed the rate of biological aging on two of the five clocks. For PCGrimAge, the between-group difference in yearly aging rate was −0.113 years, corresponding to approximately 1.4 months less biological aging. For PCPhenoAge, the difference was −0.214 years per year, corresponding to approximately 2.6 months. Combined, the multivitamin group aged biologically by approximately 20 months over the two-year period, compared to 24 months in the placebo group — a meaningful, if modest, difference. An important finding within the data: the effect was strongest in participants who had accelerated biological aging at baseline — those who were already aging faster than their chronological age predicted. As for cocoa extract: it showed no significant effect on any of the five epigenetic clocks tested, a null result that surprised some researchers given the existing literature on polyphenols and aging.
What Is Biological Age and Why Does It Matter?
To understand why this finding matters, it helps to understand the difference between chronological and biological age.
Chronological Age vs. Biological Age
Your chronological age is simply the number of years since you were born. Your biological age reflects how old your cells and tissues actually are — a measure of cumulative cellular damage, epigenetic change, and physiological decline. Two people born in the same year can have dramatically different biological ages depending on their genetics, lifestyle, nutrition, stress exposure, and health history. A 60-year-old who smokes, sleeps poorly, and eats an inflammatory diet may have a biological age of 72. A 60-year-old who exercises regularly, maintains a healthy diet, and manages stress well may have a biological age of 53. Biological age is increasingly recognized as a better predictor of disease risk and longevity than chronological age alone.
How Epigenetic Clocks Work
Epigenetic clocks are computational tools that measure specific DNA methylation patterns — chemical modifications to DNA that regulate which genes are expressed — and use them to estimate biological age. These methylation patterns change predictably with age and are influenced by environmental and lifestyle factors. The most widely validated clocks include PCGrimAge and PCPhenoAge, which are considered second-generation clocks trained to predict mortality risk and health outcomes rather than just chronological age. A third measure, DunedinPACE, is designed to estimate the current pace of aging — how rapidly someone’s biological systems are deteriorating right now. These clocks are not yet used in routine clinical care, but they are the gold standard for research into aging interventions.
Why Would a Multivitamin Affect Biological Aging?
The most compelling explanation for the COSMOS results is the micronutrient deficiency correction hypothesis. Micronutrient deficiencies are substantially more common in older adults than most people realize. Deficiencies in B vitamins (particularly B12, folate, and B6), vitamin D, magnesium, and zinc are all associated with accelerated DNA damage, impaired DNA repair, disrupted methylation pathways, and shortened telomeres — all of which contribute to faster biological aging. Aging itself impairs the absorption and metabolism of many vitamins and minerals, creating a self-reinforcing cycle in which nutritional gaps become increasingly likely and increasingly harmful over time. A daily multivitamin corrects these baseline deficiencies. It does not add nutrients beyond normal physiological levels in well-nourished individuals — but for the substantial proportion of older adults who are quietly deficient, it fills the gaps that were silently accelerating their cellular aging. This hypothesis is strongly supported by the finding that the COSMOS effect was largest in participants who had the most accelerated biological aging at baseline — precisely the group most likely to have underlying micronutrient deficiencies.
What This Study Does and Does Not Mean
The COSMOS ancillary study is genuinely significant — and it requires genuinely balanced interpretation. Here is what the evidence supports, and what it does not.
What this study means: A large, well-designed randomized controlled trial — the strongest study design in clinical research — found that a standard, inexpensive daily multivitamin slowed two out of five epigenetic aging clocks over two years. This is the first RCT of this scale to demonstrate a causal effect of multivitamins on epigenetic aging markers. That is meaningful.
What this study does not mean: The multivitamin did not reverse aging. It did not significantly affect all five clocks. The clinical significance of four months of reduced biological aging — in terms of disease risk, lifespan, or quality of life — is not yet established. Epigenetic clocks are research tools, not clinical diagnostics. Experts at the Science Media Centre have noted that these results alone are not sufficient for clinical decision-making. A multivitamin is also not a substitute for a healthy diet, regular exercise, adequate sleep, or other evidence-based longevity practices.
The appropriate framing is this: a modest effect in a well-designed study is still an effect. Over a decade of consistent supplementation, a 17% reduction in biological aging rate could compound meaningfully. For people with underlying deficiencies — which is a very large number of older adults — the benefit may be substantially larger.
Who Benefits Most from a Daily Multivitamin?
The COSMOS data and the broader nutritional science suggest that the people most likely to benefit from a daily multivitamin are:
- Adults over 65: Reduced stomach acid production with age impairs B12 absorption; vitamin D synthesis from sunlight declines; calcium and magnesium absorption decreases. Deficiencies are common even in people who eat reasonably well.
- Vegans and vegetarians: Plant-based diets are commonly deficient in B12, zinc, iron, and omega-3 fatty acids. A multivitamin covers the first three.
- People with limited sun exposure: Vitamin D deficiency is extraordinarily common globally — particularly in northern latitudes, office workers, and people who consistently cover their skin.
- Those on calorie-restricted or highly restrictive diets: Lower food volume means lower total micronutrient intake, regardless of diet quality.
- People with accelerated biological aging at baseline: The COSMOS finding directly supports this. If epigenetic testing shows accelerated aging, this population appears to have the most to gain from correcting micronutrient deficiencies.
Practical Guidance: Should You Take a Daily Multivitamin?
The evidence supports a practical, modest recommendation: a standard multivitamin-multimineral supplement — similar to Centrum Silver for adults over 50 — appears to offer a meaningful benefit for many older adults at very low cost and risk. What the evidence does not support is the use of megadose supplements, single-nutrient high-dose formulas (unless specifically indicated by a doctor), or premium “longevity” blends making dramatic anti-aging claims. Those products are not what the COSMOS trial studied, and their additional benefit is not established. Standard multivitamins are inexpensive, widely available, and carry minimal risk for most adults. They are best understood as a nutritional safety net — not a replacement for healthy habits, but a complement to them. If you have specific health conditions or take medications, consult your physician before adding any supplement, as interactions and contraindications exist for certain nutrients.
Conclusion
The COSMOS trial result matters because it is a randomized controlled trial — not an observational study, not a retrospective analysis, but a prospective experiment designed to detect causality. Its finding is modest: four months less biological aging over two years. But it is real, reproducible, and grounded in a plausible mechanism. For the many older adults who are quietly running micronutrient deficits that are silently accelerating their cellular aging, a daily multivitamin may represent one of the highest-value, lowest-cost interventions available. The biological clock is always running. The COSMOS evidence suggests that, for some people, a simple daily pill may slow it just a little — and over a lifetime, a little adds up.
